Business
Investor buzz around cannabis stocks with new treatments – Sydney Morning Herald
Cannabis startups get down to business as treatments normalised and some small stocks are winning big name backers.
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent.
Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the nation’s special access scheme for cannabis products.
Thorney bumped its stake after a private placement of 37 million shares at 5.4c each.
“The str…
-
General13 hours agoPublisher ditches David Walliams after harassment claim
-
General11 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General10 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
General13 hours agoThe Iranian-Australian community | The Spectator Australia